Free Trial

Cooper Companies (COO) Competitors

Cooper Companies logo
$99.08 +0.03 (+0.03%)
(As of 11/20/2024 ET)

COO vs. WST, ALGN, MMSI, HAE, ICUI, XRAY, NEOG, QDEL, STAA, and CERS

Should you be buying Cooper Companies stock or one of its competitors? The main competitors of Cooper Companies include West Pharmaceutical Services (WST), Align Technology (ALGN), Merit Medical Systems (MMSI), Haemonetics (HAE), ICU Medical (ICUI), DENTSPLY SIRONA (XRAY), Neogen (NEOG), QuidelOrtho (QDEL), STAAR Surgical (STAA), and Cerus (CERS). These companies are all part of the "health care supplies" industry.

Cooper Companies vs.

West Pharmaceutical Services (NYSE:WST) and Cooper Companies (NASDAQ:COO) are both large-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their community ranking, media sentiment, profitability, dividends, risk, earnings, institutional ownership, analyst recommendations and valuation.

Cooper Companies received 355 more outperform votes than West Pharmaceutical Services when rated by MarketBeat users. Likewise, 66.56% of users gave Cooper Companies an outperform vote while only 55.74% of users gave West Pharmaceutical Services an outperform vote.

CompanyUnderperformOutperform
West Pharmaceutical ServicesOutperform Votes
262
55.74%
Underperform Votes
208
44.26%
Cooper CompaniesOutperform Votes
617
66.56%
Underperform Votes
310
33.44%

West Pharmaceutical Services has a net margin of 17.37% compared to Cooper Companies' net margin of 9.45%. West Pharmaceutical Services' return on equity of 18.41% beat Cooper Companies' return on equity.

Company Net Margins Return on Equity Return on Assets
West Pharmaceutical Services17.37% 18.41% 13.74%
Cooper Companies 9.45%9.08%5.88%

West Pharmaceutical Services presently has a consensus price target of $460.33, suggesting a potential upside of 47.70%. Cooper Companies has a consensus price target of $117.00, suggesting a potential upside of 18.09%. Given West Pharmaceutical Services' higher possible upside, analysts plainly believe West Pharmaceutical Services is more favorable than Cooper Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
West Pharmaceutical Services
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67
Cooper Companies
0 Sell rating(s)
3 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.75

93.9% of West Pharmaceutical Services shares are held by institutional investors. Comparatively, 24.4% of Cooper Companies shares are held by institutional investors. 0.5% of West Pharmaceutical Services shares are held by company insiders. Comparatively, 2.0% of Cooper Companies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, West Pharmaceutical Services had 1 more articles in the media than Cooper Companies. MarketBeat recorded 19 mentions for West Pharmaceutical Services and 18 mentions for Cooper Companies. West Pharmaceutical Services' average media sentiment score of 0.78 beat Cooper Companies' score of 0.54 indicating that West Pharmaceutical Services is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
West Pharmaceutical Services
11 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Cooper Companies
8 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
4 Negative mention(s)
1 Very Negative mention(s)
Positive

West Pharmaceutical Services has higher earnings, but lower revenue than Cooper Companies. West Pharmaceutical Services is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
West Pharmaceutical Services$2.95B7.65$593.40M$6.7446.24
Cooper Companies$3.80B5.19$294.20M$1.8055.04

West Pharmaceutical Services has a beta of 1, meaning that its share price has a similar volatility profile to the S&P 500.Comparatively, Cooper Companies has a beta of 0.99, meaning that its share price is 1% less volatile than the S&P 500.

Summary

West Pharmaceutical Services beats Cooper Companies on 11 of the 18 factors compared between the two stocks.

Get Cooper Companies News Delivered to You Automatically

Sign up to receive the latest news and ratings for COO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

COO vs. The Competition

MetricCooper CompaniesOphthalmic goods IndustryMedical SectorNASDAQ Exchange
Market Cap$19.73B$11.35B$5.04B$8.82B
Dividend YieldN/A1.63%5.17%4.07%
P/E Ratio55.2035.06122.4217.58
Price / Sales5.194.701,179.2973.96
Price / Cash19.6317.4233.5632.51
Price / Book2.603.554.694.68
Net Income$294.20M$224.33M$118.98M$225.87M
7 Day Performance-2.75%-0.12%-2.45%-2.03%
1 Month Performance-8.48%0.70%-4.03%0.07%
1 Year Performance17.25%16.00%29.80%24.55%

Cooper Companies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
COO
Cooper Companies
3.4795 of 5 stars
$99.08
+0.0%
$117.00
+18.1%
+17.3%$19.73B$3.80B55.2015,000Analyst Downgrade
WST
West Pharmaceutical Services
4.9656 of 5 stars
$311.67
+2.5%
$460.33
+47.7%
-10.7%$22.02B$2.95B46.2410,600Analyst Revision
ALGN
Align Technology
4.6504 of 5 stars
$223.87
+0.6%
$276.38
+23.5%
+4.0%$16.71B$3.96B38.2021,610Positive News
MMSI
Merit Medical Systems
4.4368 of 5 stars
$104.08
-0.6%
$103.36
-0.7%
+44.9%$6.07B$1.26B51.026,950Insider Trade
Positive News
HAE
Haemonetics
4.9252 of 5 stars
$84.92
+0.1%
$107.88
+27.0%
+2.4%$4.26B$1.36B35.243,657
ICUI
ICU Medical
4.029 of 5 stars
$167.59
-1.2%
$173.00
+3.2%
+94.1%$4.15B$2.34B-36.6714,000Analyst Upgrade
Short Interest ↓
XRAY
DENTSPLY SIRONA
4.8915 of 5 stars
$18.52
-1.9%
$29.50
+59.3%
-38.1%$3.75B$3.97B0.0015,000Analyst Downgrade
NEOG
Neogen
2.153 of 5 stars
$14.90
-1.3%
$17.50
+17.4%
-8.5%$3.23B$912.20M-135.452,640
QDEL
QuidelOrtho
4.5798 of 5 stars
$37.48
-2.9%
$58.83
+57.0%
-45.1%$2.59B$3.00B0.007,100Analyst Forecast
Gap Down
High Trading Volume
STAA
STAAR Surgical
4.8425 of 5 stars
$26.32
+0.7%
$43.33
+64.6%
-24.3%$1.29B$322.42M59.821,115
CERS
Cerus
2.6511 of 5 stars
$1.66
-1.2%
$3.63
+118.4%
-7.3%$308.29M$176.23M-15.09625Positive News

Related Companies and Tools


This page (NASDAQ:COO) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners